siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury
about
Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosisRemedial applications of silencing ribonucleic acids and modalities for its delivery to the kidneys--a reviewMechanisms of Cisplatin nephrotoxicityFighting against kidney diseases with small interfering RNA: opportunities and challengesSmall RNA Detection by in Situ Hybridization MethodsAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityCisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment StrategiesPathogenesis of acute kidney injury: foundation for clinical practice.Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammationTherapeutic translation in acute kidney injury: the epithelial/endothelial axisAugmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.MDM2 prevents spontaneous tubular epithelial cell death and acute kidney injury.Advances in Systemic siRNA DeliveryInhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells.DNA damage response in renal ischemia-reperfusion and ATP-depletion injury of renal tubular cellsRegulation of necrotic cell death: p53, PARP1 and cyclophilin D-overlapping pathways of regulated necrosis?Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes.Pathologies associated with the p53 response.Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.Multiple analytical approaches demonstrate a complex relationship of genetic and nongenetic factors with cisplatin- and carboplatin-induced nephrotoxicity in lung cancer patientsTubular p53 regulates multiple genes to mediate AKIAnalysis of plant-derived miRNAs in animal small RNA datasetsDynamic multiphoton microscopy: focusing light on acute kidney injury.Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment.Aqp5 is a new transcriptional target of Dot1a and a regulator of Aqp2.Targeted deletion of p53 in the proximal tubule prevents ischemic renal injuryA method to facilitate and monitor expression of exogenous genes in the rat kidney using plasmid and viral vectors.Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury.Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice.TIGAR regulates glycolysis in ischemic kidney proximal tubules.Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury.Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functionsInhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancerHarnessing RNAi nanomedicine for precision therapyPolycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane.MicroRNA-687 Induced by Hypoxia-Inducible Factor-1 Targets Phosphatase and Tensin Homolog in Renal Ischemia-Reperfusion Injury.Folate receptor-targeted antioxidant therapy ameliorates renal ischemia-reperfusion injury.Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.The first decade of using multiphoton microscopy for high-power kidney imaging.The p53 inhibitor pifithrin-α can stimulate fibrosis in a rat model of ischemic acute kidney injury.
P2860
Q26796688-E9A3C555-AFB4-475A-A53D-A62C583F17F2Q26995395-C7020CF5-03C6-43D4-94BC-27F26DC7C26AQ26996320-89466934-ECCB-4DD3-A5A7-A72B53FB6FF6Q27010574-EBA93F57-6BAC-42A0-B0B4-2B40D892553BQ27011992-D74830DF-A81B-45A2-B46E-A445F531CCF9Q28080615-5BBE6590-8EDC-40EE-B1A8-619B96AC87D7Q28080842-8C92C0B8-56CD-4499-9626-8D03668556A4Q30425669-BCD0DCF8-2550-4275-B4F0-BAAAE29ECE75Q30473608-A93F0451-0630-4850-AFC8-82F36E5780AEQ30583254-2AA1302C-18E6-43DE-8856-4F97AC3E6354Q30669518-ACBD12B8-C3C9-4732-8C78-0A6B7D7674EBQ30836168-356901F3-1199-49E5-B0A7-B330CDD7E87FQ33613316-2F13CAB1-64A8-455D-A5ED-024542837811Q33655696-F6FE0259-338B-47D3-ACD2-1DED4CFB8394Q33684961-D36C05FE-C1E1-432C-B512-8A9EBEDCC897Q33851480-AD4B2872-085F-4522-8A08-9A0A094A2041Q33902809-11585812-1293-452D-8C77-74B48F718524Q33931980-1F833673-88D8-4E3A-805C-8BDE03667177Q34080235-6AD6A802-4932-4D2B-A048-48010143D1ACQ34177673-F86597B6-079D-439C-AE8E-3BF546B4D2C1Q34260039-6FAE8AD6-7FC3-4755-92EA-FD2BF887EEC9Q34371445-7F65D752-A303-4B50-B5E9-58EC2BB5C1D4Q34428919-E3DE7CA2-CF8E-47C8-804A-C139A323C518Q34482537-4CE7FE51-8F07-4D07-9B63-7013BD688EB1Q34551326-D4A5D4D8-AF3A-4E9A-BF11-6253090ED7D0Q34568811-F5670E4C-3973-410D-8F60-7D710BA16DEEQ34610689-35870739-F4B6-439F-82D6-316A91932B02Q34774010-4F28AC85-89EB-4852-86D8-1E7E70A2C10AQ34785218-A876C676-B2D8-4603-A267-6F6371D197A7Q35086457-D7155C8D-1686-4192-8BAA-1FB6E0131675Q35207826-77BEFC4C-1CDC-4E31-B39D-9C1D23EEF32FQ35549264-BC24301B-89D0-470B-A385-162EDC6D1D61Q35572426-C6D7553E-66F1-4D04-AAA5-7F28011B515DQ35673875-8A809113-4614-49A6-B47E-19E25576ACC8Q35778918-C24DBDBD-3F30-40EF-9131-52E7DB839596Q35790556-AB66C932-55BC-4896-AB62-413C2EBBDABBQ35917491-2804EB82-93EA-4C9D-ACF6-E494CF85F1D3Q35917703-176AFC18-7E91-4E18-93DD-BDC1F726BE41Q35924486-D0AD34A3-37A9-4B4C-BF52-3C5BF0508304Q35924490-933F9BC3-4838-4097-9584-78FE8C3E84F8
P2860
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury
@en
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury.
@nl
type
label
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury
@en
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury.
@nl
prefLabel
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury
@en
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury.
@nl
P2093
P2860
P356
P1476
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury
@en
P2093
Alexander Faerman
Anat Brafman
Bruce A Molitoris
Eduard Fridman
Elena Feinstein
Hagar Kalinski
Hagit Ashush
James D Thompson
Pierre C Dagher
Rami Skaliter
P2860
P304
P356
10.1681/ASN.2008111204
P577
2009-05-21T00:00:00Z